GPC3-Targeted PET Imaging of 18F-X12 in Hepatocellular Carcinoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a diagnostic study. This clinical trial aims to evaluate the diagnostic performance and safety of the novel radiotracer 18F-X12 in patients with hepatocellular carcinoma (HCC), and to provide evidence supporting a new approach for its early diagnosis, accurate staging and recurrence assessment.
Epistemonikos ID: d612ca5a232124ca94cb9c92f26c0b97bda95c1d
First added on: Sep 01, 2026